Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» earnings
earnings
Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline
Fierce Pharma
Sun, 03/10/24 - 08:40 pm
Merck KGaA
earnings
CDMOs
Food allergy biotech DBV is running out of cash, with phase 3 trials underway
Fierce Biotech
Fri, 03/8/24 - 11:32 am
DBV Technologies
food allergies
earnings
clinical trials
peanut allergy
Sarepta’s Duchenne Gene Therapy Elevidys Nabs $200M on Strong Demand
BioSpace
Thu, 02/29/24 - 11:00 am
Sarepta Therapeutics
gene therapy
Elevidys
earnings
Duchenne Muscular Dystrophy
After steep cost cuts, Novavax's fourth-quarter performance falls short of expectations
Fierce Pharma
Wed, 02/28/24 - 10:46 am
Novavax
earnings
BioMarin preaches patience amid slow sales for hemophilia gene therapy
BioPharma Dive
Fri, 02/23/24 - 10:26 am
Biomarin
Roctavian
earnings
gene therapy
hemophilia
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Fierce Pharma
Thu, 02/22/24 - 11:12 pm
earnings
Novo Nordisk
Eli Lilly
obesity
Moderna posts surprise quarterly profit as it eyes RSV vaccine approval
Medical Marketing and Media
Thu, 02/22/24 - 11:49 am
Moderna Therapeutics
earnings
vaccines
RSV
COVID-19
Medtronic lifts annual profit forecast, exits ventilator business
Reuters
Tue, 02/20/24 - 11:14 am
Medtech
Medtronic
earnings
ventilators
Blueprint boosts Ayvakit peak sales estimate to $2B as key rare disease expansion accelerates
Fierce Pharma
Thu, 02/15/24 - 11:13 am
Blueprint Medicines
Ayvakit
earnings
Biogen sees flat 2024 sales, pick up in Alzheimer's drug demand
Reuters
Tue, 02/13/24 - 11:31 am
Biogen
earnings
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
As Catalent prepares to join Novo family, CDMO's sales continue to slide
Fierce Pharma
Fri, 02/9/24 - 11:21 am
Catalent
CDMOs
earnings
Novo Nordisk
AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed
Medical Marketing and Media
Thu, 02/8/24 - 11:23 am
AstraZeneca
earnings
COVID-19
Obesity drug mania takes over Amgen’s earnings call
BioPharma Dive
Wed, 02/7/24 - 09:17 pm
Amgen
earnings
GLP-1 agonist
obesity
AMG-133
CVS cuts 2024 profit forecast as medical care drives costs higher
Reuters
Wed, 02/7/24 - 11:31 am
CVS Health
earnings
Pfizer's Problems Go Far Beyond Just Declining COVID Revenue
Motley Fool
Wed, 02/7/24 - 11:20 am
Pfizer
COVID-19
earnings
Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops
Medical Marketing and Media
Tue, 02/6/24 - 11:41 pm
Amgen
Gilead Sciences
earnings
Horizon Therapeutics
M&A
Lilly expects strong 2024 profit on rising weight-loss drug demand
Reuters
Tue, 02/6/24 - 10:16 am
Eli Lilly
earnings
Zepbound
Mounjaro
Astellas' sales expectations are up for Padcev, down for Veozah
Fierce Pharma
Mon, 02/5/24 - 11:02 pm
Astellas
earnings
Padcev
BMS more likely to bet on bolt-ons after recent buying spree
Fierce Biotech
Fri, 02/2/24 - 11:59 am
Bristol Myers Squibb
M&A
earnings
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »